As of August 28, 2026, Celldex Therapeutics, Inc. (CLDX) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Celldex Therapeutics, Inc. has a market capitalization of $2.47B, 78.53M shares outstanding, 232 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CLDX.
Market Data
Market Cap$2.47B
Shares Outstanding78.53M
Float72.46M
Cash$717.59M
Debt$1.91M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 8.0% shares (2026Q1 vs prior)
232 institutional holders · 80.73M shares
#1
WELLINGTON MANAGEMENT GROUP LLP
8.56M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
5.92M shares
#3
Kynam Capital Management, LP
5.84M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest7.63M
Days to Cover7.6
% of Float10.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CLDX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLDX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CLDX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.